ESPR · Categories · Coverage
ESPR - Analyst coverage initiated
Esperion Therapeutics Inc. (ESPR) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for ESPR
- Piper Sandler initiated coverage on Esperion Therapeutics with a new price targetPiper Sandler initiated coverage of Esperion Therapeutics with a rating of Overweight and set a new price target of $9.00
- Goldman initiated coverage on Esperion Therapeutics with a new price targetGoldman initiated coverage of Esperion Therapeutics with a rating of Neutral and set a new price target of $4.00
- Cantor Fitzgerald initiated coverage on Esperion Therapeutics with a new price targetCantor Fitzgerald initiated coverage of Esperion Therapeutics with a rating of Overweight and set a new price target of $8.00
- HC Wainwright & Co. initiated coverage on Esperion Therapeutics with a new price targetHC Wainwright & Co. initiated coverage of Esperion Therapeutics with a rating of Buy and set a new price target of $22.00
- Morgan Stanley initiated coverage on Esperion TherapeuticsMorgan Stanley initiated coverage of Esperion Therapeutics with a rating of Equal Weight
- Morgan Stanley initiated coverage on Esperion Therapeutics with a new price targetMorgan Stanley initiated coverage of Esperion Therapeutics with a rating of Equal-Weight and set a new price target of $30.00